BostonGene and Exigent Genomic INsight Study

Part of paid clinical trials in Rogers, Arkansas.

Sponsor
BostonGene
Study ID
NCT06272864
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.

Key Dates

Start date
Apr 8, 2024
Status verified
Feb 2025
Primary completion
Jan 8, 2026
Completion
Jan 8, 2028

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Breast cancer
    Patients with locally recurrent, unresectable or metastatic breast cancer
  • Arm: NSCLC
    Patients with unresectable stage III or metastatic non-small cell lung cancer
  • Arm: Melanoma
    Patients with unresectable or metastatic melanoma
  • Arm: Sarcoma
    Patients with locally advanced or metastatic sarcoma

Primary Outcome Measure

Frequency of actionable findings [ Time Frame: 2 years ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Highlands Oncology GroupRogersArkansas72758
Eric Schaefer, MD (PRINCIPAL_INVESTIGATOR)
Stockton Hematology Oncology Medical GroupStocktonCalifornia95204
Lizbeth Ortiz
[email protected]
Dheeraj Kodali, MD (PRINCIPAL_INVESTIGATOR)
Fort Wayne Medical Oncology and HematologyFort WayneIndiana46804
Sunil Babu, MD (PRINCIPAL_INVESTIGATOR)
New Mexico Cancer CenterAlbuquerqueNew Mexico87109
Valerie Tucker
[email protected]
Katherine Sanchez, MD (PRINCIPAL_INVESTIGATOR)
Oklahoma Cancer Specialists and Research InstituteTulsaOklahoma74146
Paul Zito, MD (PRINCIPAL_INVESTIGATOR)
Oncology ConsultantsHoustonTexas77030
Laura Guerra
[email protected]
Julio Peguero, MD (PRINCIPAL_INVESTIGATOR)
Northwest Medical SpecialitiesPuyallupWashington98373
Sibel Blau, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rogers, AR

By condition
Breast cancerMelanomaLung cancer
By specialty
OncologyBreast oncologyWomen's healthSkin cancerDermatologyLung oncologyLung disease
By research site
Highlands Oncology Group· Rogers, ARStockton Hematology Oncology Medical Group· Stockton, CAFort Wayne Medical Oncology and Hematology· Fort Wayne, INNew Mexico Cancer Center· Albuquerque, NMOklahoma Cancer Specialists and Research Institute· Tulsa, OKOncology Consultants· Houston, TX

Related Studies